CA2532330C - Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation - Google Patents

Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation Download PDF

Info

Publication number
CA2532330C
CA2532330C CA002532330A CA2532330A CA2532330C CA 2532330 C CA2532330 C CA 2532330C CA 002532330 A CA002532330 A CA 002532330A CA 2532330 A CA2532330 A CA 2532330A CA 2532330 C CA2532330 C CA 2532330C
Authority
CA
Canada
Prior art keywords
disorder
reboxetine
disorders
reuptake
norepinephrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002532330A
Other languages
English (en)
Other versions
CA2532330A1 (fr
Inventor
Erik H.F. Wong
Saeeduddin Ahmed
Robert Clyde Marshall
Robert Mcarthur
Duncan P. Taylor
Lars Birgerson
Pasquale Cetera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co filed Critical Pharmacia and Upjohn Co
Priority claimed from CA002375908A external-priority patent/CA2375908C/fr
Publication of CA2532330A1 publication Critical patent/CA2532330A1/fr
Application granted granted Critical
Publication of CA2532330C publication Critical patent/CA2532330C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002532330A 1999-07-01 2000-06-22 Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation Expired - Fee Related CA2532330C (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US14196899P 1999-07-01 1999-07-01
US60/141,968 1999-07-01
US14413199P 1999-07-16 1999-07-16
US60/144,131 1999-07-16
US15825699P 1999-10-06 1999-10-06
US60/158,256 1999-10-06
US17038199P 1999-12-13 1999-12-13
US60/170,381 1999-12-13
CA002375908A CA2375908C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002375908A Division CA2375908C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation

Publications (2)

Publication Number Publication Date
CA2532330A1 CA2532330A1 (fr) 2001-01-11
CA2532330C true CA2532330C (fr) 2009-04-21

Family

ID=36141768

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002532330A Expired - Fee Related CA2532330C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation
CA002543986A Expired - Fee Related CA2543986C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002543986A Expired - Fee Related CA2543986C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes

Country Status (1)

Country Link
CA (2) CA2532330C (fr)

Also Published As

Publication number Publication date
CA2532330A1 (fr) 2001-01-11
CA2543986A1 (fr) 2001-01-11
CA2543986C (fr) 2009-03-03

Similar Documents

Publication Publication Date Title
CA2375908C (fr) Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation
EP1632235A2 (fr) utilisation d' inhibiteurs de recaptage de noradrenaline hautement selectifs pour traiter les maladies mentales
CA2532330C (fr) Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation
NZ542816A (en) Optically pure (S.S) reboxetine in the treatment of conditions such as those involving addiction and TIC disorders in which inhibiting reuptake of norepinephrine (nor adrenaline) provides relief
NZ550213A (en) Use of racemic reboxetine for the treatment of chronic fatigue syndrome, fibromyalgia or another somatoform disorder, migraine headaches and peripheral neuropathy

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed